Abstract |
Liposomal cis-bis-neodecanato-trans-R,R-1,2-diaminocyclohexaneplatinum (11) ( L-NDDP) is a liposome-entrapped platinum complex that has shown partial lack of cross-resistance with cisplatin in human colon carcinoma LoVo cells. We studied the drug accumulation and DNA damage induced by L-NDDP and cisplatin in LoVo and LoVo/PDD cells. Our results indicate that the accumulation of L-NDDP in LoVo cells is several-fold higher than that of cisplatin; that the accumulation of L-NDDP is similar in both cell lines, whereas that of cisplatin is reduced by 2- to 3-fold in LoVo/PDD cells; and that the transmembrane transport of cisplatin is highly dependent on temperature while that of L-NDDP is not. We also found that the cytotoxicity of both agents correlates with the extent of DNA- protein cross-link formation, and that DNA interstrand cross-linking does not appear to play a role in the cytotoxicity of L-NDDP, whereas it correlates with cisplatin cytotoxicity.
|
Authors | I Han, T Nguyen, L Y Yang, A R Khokhar, R Perez-Soler |
Journal | Anti-cancer drugs
(Anticancer Drugs)
Vol. 5
Issue 1
Pg. 64-8
(Feb 1994)
ISSN: 0959-4973 [Print] England |
PMID | 8186432
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antineoplastic Agents
- Cross-Linking Reagents
- DNA, Neoplasm
- Drug Carriers
- Liposomes
- Neoplasm Proteins
- Organoplatinum Compounds
- bis-neodecanoato-1,2-diaminocyclohexaneplatinum(II)
- Cisplatin
|
Topics |
- Antineoplastic Agents
(pharmacokinetics, therapeutic use)
- Carcinoma
(drug therapy, metabolism)
- Cell Survival
(drug effects)
- Cisplatin
(pharmacokinetics, pharmacology)
- Colonic Neoplasms
(drug therapy, metabolism)
- Cross-Linking Reagents
(pharmacology)
- DNA Damage
- DNA, Neoplasm
(drug effects, metabolism)
- Drug Carriers
- Humans
- Liposomes
- Neoplasm Proteins
(drug effects, metabolism)
- Organoplatinum Compounds
(pharmacokinetics, therapeutic use)
- Temperature
- Tumor Cells, Cultured
|